<DOC>
	<DOC>NCT02413541</DOC>
	<brief_summary>This research project is a study to immunology changes in critically ill patients with severe sepsis by using Endotoxin Activity Assay (EAA) combined with Polymyxin-B Hemoperfusion.</brief_summary>
	<brief_title>The Pilot Study of the Efficacy of Polymyxin-B Hemoperfusion in Critically Ill Patients With Severe Sepsis</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Polymyxin B</mesh_term>
	<mesh_term>Polymyxins</mesh_term>
	<criteria>SIRS Criteria &gt; or = 2 meets definition Source of infection &gt; or = 1 meet definition Evidence of organ dysfunction &gt; or = 1 meet definition WBC &lt; 5,000 /ul Platelet &lt; 30,000 / ul Pregnancy woman Advance stage cancer patients (terminally ill) who is refuse to be resuscitated Received blood transfusion &gt; 5 units in 24 hrs Allergy to PolymyxinB High risk and uncontrolled bleeding Organ transplant patients On immunosuppressive agents within 2 weeks before study HIV infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>